Pseudomyxoma peritonei primary prevention

Pseudomyxoma peritonei Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Pseudomyxoma peritonei from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pseudomyxoma peritonei primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pseudomyxoma peritonei primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pseudomyxoma peritonei primary prevention
CDC on Pseudomyxoma peritonei primary prevention
Pseudomyxoma peritonei primary prevention in the news
Blogs on Pseudomyxoma peritonei primary prevention
Directions to Hospitals Treating Pseudomyxoma peritonei
Risk calculators and risk factors for Pseudomyxoma peritonei primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the primary prevention of Pseudomyxoma peritonei.

Primary Prevention

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include:

• [Measure1]
• [Measure2]
• [Measure3]

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:

• [Strategy 1]
• [Strategy 2]
• [Strategy 3]